7Kajstura J,Cheng W,Reiss K,et al.Apoptotic and necmtic myocytecell deaths are independent contributing variables of infarct size in rats[J].Lab Invest,1996,74(1):86-107.
8Ling H,Lou Y.Total flavones from Elsholtzia blanda reduce infarct size during acute myocardial ischemia by inhibiting myocardial apoptosis in rats[J].J Ethnopharmacol,2005,101(1-3):169-l75.
9Qin F,Liang MC,Liang CS.Progressive left ventricular remodeling,myocyte apoptosis and protein signaling cascades after myocardial Infarction in rabbits[J].Biochim Biophys Acta,2005,1740(3):499-513.
10Soeda J,Miyagawa S,Sano K,et al.Cytochrome Crelease into cytosol with subsequent caspase activating during warm ischemia In rat liver[J].Am J Physiol Gestrointest Liver Physiol,2001,281(4):G1115-G1123.
5Donato M, Annunzio V, Buchholz B, et al. Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning[J]. Exp Physiol, 2010,95 (2) : 74-81.
6Kandasamy A D, Chow A K, Ali M A, et al. Matrix metalloproteinase-2 and myocardial oxidative stress injury~ beyond the matrix[J]. Cardiovasc Res,2010,85(3) :13-23.
7Cheung P Y, Sawicki G, Wozniak M, et al. Matrix metalloproteinase 2 contributes to ischemia-reperfusion injury in the heart[J].Circulation, 2000,101 (15) : 1833-1839.
8Lindsey M, Wedin K, Brown M D, et al. Matrix-dependent mechanism of Neutrophil mediated release and activation of matrix metalloproteinase-9 in myocardial ischemia reperfusion [J]. Circulation,2001,103(17) :218-271.
9Yasuda S, Miyazaki S, Kinoshita H, et al. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction[J]. Clin Sci (Lond), 2007,112 (1) :43-49.
10Oyamada S, Bianchi C, Takai S, et al. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion[J].J Pharmacol Exp Ther, 2011,339 ( 1 ) : 143-151.
